Near-high EPS growers
Query: US large-cap stocks within 5% of their 52-week high with EPS growth above 20% · data as of 2026-10-09
Built a sortable table of 39 US large caps (>$10B) trading within 5% of their 52-week high with EPS growth >20% YoY, ranked closest to the high (tie-broken by EPS growth), with sector/industry, market cap, 52W-high distance, EPS and revenue growth, P/E and forward P/E, 1M/6M returns, % above 150D SMA, momentum potential and days since last earnings — plus per-name qualitative comments and a screen narrative.
42 US large caps (over $10B market cap) are trading within 5% of their 52-week high while still growing earnings more than 20% year over year — the classic 'leadership with fundamental fuel' setup. Software/infrastructure dominates (Palantir, Okta, Nutanix, Microsoft, Arista), with a secondary cluster in energy refining and health care. Most names sit well above their 150-day averages and carry very high momentum scores, but many have already reported earnings (60+ days since), so the next catalyst for the group is the coming quarterly print rather than a recent one.
Near 52-Week Highs with >20% EPS Growth
| Symbol | Security Name | Sector | Industry | Market Cap | % from 52-Week High | EPS Growth YoY | Revenue Growth YoY | P/E (TTM) | Forward P/E | 1M Return | 6M Return | % above 150D SMA | Momentum Potential | Days Since Last Earnings | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OKTA | Okta, Inc. | Information Technology | Software - Infrastructure | 4.058e+10 | 0.00% | 739.29% | 11.84% | 168.21 | 54.16 | 35.66% | 268.87% | 84.93% | 98.6 | 43 | Identity-security demand is being re-underwritten by AI-agent deployment, which multiplies the number of machine and human identities to be governed. Okta sits at the center of that toll road, but the stock is priced as if the reacceleration is permanent — execution on large enterprise deals is the swing factor. |
| NTNX | Nutanix, Inc. | Information Technology | Software - Infrastructure | 2.019e+10 | 0.00% | 250.96% | 18.11% | 78.56 | 34.05 | 14.08% | 116.88% | 39.88% | 94.1 | 43 | The private-cloud / hyperconverged story is now a genuine AI infrastructure play: enterprises refreshing virtualization stacks ahead of Broadcom's VMware repricing are a structural tailwind. Profitability inflection is the setup; competition from public cloud and hardware vendors is the risk. |
| PLTR | Palantir Technologies Inc. | Information Technology | Software - Infrastructure | 5.024e+11 | 0.00% | 249.34% | 56.18% | 178.68 | 90.33 | 26.04% | 63.24% | 38.78% | 100 | 66 | The clearest AI-adoption landlord in the screen — government and commercial AIP deployments keep expanding the deal count, which is what the multiple is underwriting. Valuation leaves almost no room for a bookings miss, so guidance is the entire thesis. |
| GME | GameStop Corporation | Consumer Discretionary | Specialty Retail | 1.34e+10 | 0.00% | 218.66% | -5.05% | 19.82 | 19.39 | 30.26% | 14.38% | 19.90% | 85.9 | 31 | Retail-trader flow and a cash-rich balance sheet drive the tape rather than operating earnings, so the EPS-growth optics here say little about the business. Treat any rally as sentiment-driven; the core software and collectibles pivot is still unproven. |
| DINO | HF Sinclair Corporation | Energy | Oil & Gas Refining & Marketing | 2.157e+10 | 0.00% | 218.48% | -5.99% | 11.56 | 12.94 | 12.61% | 113.70% | 52.47% | 79.5 | 73 | Refining margins are the entire earnings story — crack spreads have been unusually wide on tight global distillate supply, and HF Sinclair's renewables segment adds both upside and volatility. The elevated 6M return reflects a commodity cycle, not a durable earnings franchise. |
| TEVA | Teva Pharmaceutical Industries | Health Care | Drug Manufacturers - Specialty & Generic | 4.793e+10 | 0.00% | 186.03% | 4.32% | 68.5 | 13.36 | 13.07% | 34.67% | 20.15% | 92.2 | 72 | The generic-drug turnaround is finally showing up in reported profit, helped by a leaner cost base and branded assets like Austedo and Ajovy. The forward multiple is a fraction of the trailing one, implying the market expects big EPS normalization from a low base — leverage and US pricing pressure remain the key risks. |
| WBD | Warner Bros. Discovery, Inc. - | Communication Services | Entertainment | 7.76e+10 | 0.00% | 106.52% | -5.15% | 106.72 | — | 9.09% | 12.91% | 12.63% | 35.5 | 60 | Debt-reduction and streaming economics are the swing factors after the split-driven re-rating; the market is paying for deleveraging progress rather than organic growth. Considerable balance-sheet leverage makes this a headline-sensitive holding. |
| P | Everpure, Inc. | Information Technology | Computer Hardware | 5.148e+10 | 0.00% | 76.30% | 15.61% | 169.7 | 50.28 | 64.18% | 153.51% | 83.15% | 94.1 | 43 | A pure-play beneficiary of AI server buildouts, with networking and power content per rack rising sharply. The setup is strong order momentum, but a single product cycle means the earnings trajectory is tied very closely to hyperscaler capex decisions. |
| RGA | Reinsurance Group of America, I | Financials | Insurance - Reinsurance | 1.672e+10 | 0.00% | 64.23% | 7.20% | 11.27 | 8.65 | 3.45% | 23.89% | 14.95% | 76.6 | 63 | Reinsurance underwriting is at the favorable end of its cycle with hard pricing on property-catastrophe risk, and the balance-sheet leverage to higher rates flatters results. The risk is a normalizing rate environment and a heavy catastrophe season. |
| PM | Philip Morris International Inc | Consumer Staples | Tobacco | 3.136e+11 | 0.00% | 57.91% | 7.31% | 27.64 | 21.94 | 6.93% | 27.51% | 13.00% | 73.1 | 79 | Smoke-free products now carry the growth and pricing power while the combustible business funds a large capital-return program. The setup is defensive and cash-generative, but regulatory and litigation headlines around nicotine pouches are the tail risk. |
| EXEL | Exelixis, Inc. | Health Care | Biotechnology | 1.483e+10 | 0.00% | 50.13% | 6.98% | 18.82 | 14.71 | 4.23% | 35.22% | 16.50% | 98.4 | 64 | A rare profitable mid-cap biotech: the cabozantinib franchise throws off strong cash flow and the pipeline is being funded internally rather than with dilution. Patent-cliff timing on the lead drug is the principal overhang. |
| ANET | Arista Networks, Inc. | Information Technology | Computer Hardware | 2.734e+11 | 0.00% | 23.12% | 28.60% | 68.37 | 42.01 | 14.68% | 47.09% | 27.49% | 99.9 | 65 | Beneficiary of the shift to 400G/800G Ethernet in AI data centers, where its switching software and optics take share from incumbents. Hyperscaler concentration means the order book is lumpy, and the valuation already embeds years of double-digit growth. |
| FFIV | F5, Inc. | Information Technology | Software - Infrastructure | 2.717e+10 | 0.00% | 22.16% | 9.66% | 38.2 | 26.54 | 20.42% | 65.57% | 27.47% | 98.6 | 73 | Application-delivery and security refresh demand is driving a modest but profitable growth reacceleration, which is why the multiple expanded off a low base. Absent a product cycle, the story is more of a cash-return and margin story than a growth one. |
| AMG | Affiliated Managers Group, Inc. | Financials | Asset Management | 1.001e+10 | 0.00% | 22.06% | 1.64% | 13.59 | 9.19 | 9.23% | 35.72% | 16.70% | 98.7 | 71 | Asset management earnings are levered to markets and performance fees, and the stock's re-rating reflects a strong fundraising backdrop plus meaningful share buybacks. Beta to equity markets is the main risk for a name this extended. |
| ELPC | Companhia Paranaense de Energia | Utilities | Utilities - Regulated Electric | 1.053e+10 | 0.00% | 20.29% | 5.45% | 17.3 | 19.87 | 11.64% | 7.97% | 18.97% | 63 | 64 | A Brazilian regulated utility with a stabilization story: tariff resets and a stronger real are driving the earnings step-up. Currency and Brazilian political risk are the reasons it trades at a discount to US peers. |
| DELL | Dell Technologies Inc. | Information Technology | Computer Hardware | 3.726e+11 | -0.40% | 29.27% | 18.80% | 46.66 | 26.21 | 15.68% | 231.18% | 60.95% | 98.8 | 37 | AI-server and storage demand has transformed the growth profile of a historically low-multiple hardware name, but hardware margins remain thin and the earnings are backlog-dependent. The setup hinges on how much of the AI order book converts into revenue. |
| JCI | Johnson Controls International | Industrials | Building Products & Equipment | 9.537e+10 | -0.83% | 84.89% | 2.81% | 44.35 | 26.1 | 10.55% | 11.08% | 10.97% | 67.9 | 72 | Data-center cooling and building-efficiency demand is a quiet beneficiary of AI capex, complementing a services-heavy backlog. The re-rating reflects margin expansion and portfolio simplification, so the risk is a slower non-residential construction cycle. |
| VEEV | Veeva Systems Inc. | Health Care | Health Information Services | 4.795e+10 | -0.99% | 27.27% | 16.34% | 52.6 | 29.53 | 13.47% | 95.56% | 46.36% | 99.7 | 43 | Life-sciences CRM with high retention and a clean balance sheet; growth is steady rather than explosive, which makes the reacceleration into new modules and clinical data the key proof point. Attractive quality profile, but the multiple assumes flawless execution. |
| PSX | Phillips 66 | Energy | Oil & Gas Refining & Marketing | 1.115e+11 | -1.21% | 108.18% | -7.53% | 15.87 | 13.09 | 7.61% | 76.88% | 39.00% | 77.2 | 65 | Refining and midstream cash flow is at a cyclical high on wide distillate cracks, supporting large distributions and buybacks. Earnings are inherently commodity-driven, so this is a margin-cycle trade more than a compounder. |
| MSFT | Microsoft Corporation | Information Technology | Software - Infrastructure | 3.973e+12 | -1.29% | 31.34% | 17.79% | 29.79 | 22.7 | 8.66% | 44.86% | 23.90% | 95.9 | 71 | Azure and AI infrastructure spending remain the primary growth engine, with Copilot monetization as the incremental lever. Enormous scale makes it a core holding, but the earnings are increasingly sensitive to data-center depreciation and capex discipline. |
| APH | Amphenol Corporation | Information Technology | Electronic Components | 2.151e+11 | -1.56% | 76.33% | 51.71% | 21.76 | 13.57 | 8.88% | 24.34% | 15.67% | 99.6 | 72 | Interconnect and connector content rises with every AI rack and every electrification project, giving the company two secular demand vectors at once. Acquisitive growth has been additive, though the multiple now reflects a lot of that runway. |
| ESTC | Elastic N.V. | Information Technology | Software - Application | 1.031e+10 | -1.68% | 440.17% | 17.26% | 28.64 | 25.34 | 17.67% | 126.86% | 50.56% | 97.3 | 42 | Search-driven analytics sits directly on the enterprise AI data wave, and the business has crossed into durable profitability. The re-rating came fast; the risk is a competitive field where cloud vendors bundle similar functionality. |
| RNR | RenaissanceRe Holdings Ltd. | Financials | Insurance - Reinsurance | 1.377e+10 | -1.95% | 22.20% | 9.86% | 5.75 | 8.08 | 1.61% | 9.64% | 6.74% | 40.7 | 78 | Property-catastrophe reinsurance pricing remains firm, and the company's capital-light fee businesses smooth the underwriting cycle. The setup is strong but the stock is a levered bet on benign catastrophe losses. |
| ASX | ASE Technology Holding Co., Ltd | Information Technology | Semiconductors | 1.021e+11 | -2.31% | 27.34% | 13.30% | 56.62 | 25.22 | 16.48% | 88.80% | 32.53% | 97.4 | 71 | Advanced packaging and test are the chokepoint of AI-chip supply, so this outsourced assembly leader benefits regardless of which designer wins. The catch is that results are heavily tied to a handful of leading-edge customers. |
| GILD | Gilead Sciences, Inc. | Health Care | Drug Manufacturers - General | 1.874e+11 | -2.97% | 1672.92% | 2.40% | 22.3 | 15.28 | 4.98% | 10.09% | 11.08% | 82.6 | 65 | HIV franchise durability plus a fast-growing oncology portfolio are driving the profit inflection, and the valuation is still undemanding relative to large-cap pharma. Patent expirations later this decade are the known overhang. |
| EHC | Encompass Health Corporation | Health Care | Medical Care Facilities | 1.217e+10 | -3.03% | 27.24% | 10.46% | 20.56 | 18.47 | 2.07% | 15.41% | 12.37% | 44.2 | 64 | Post-acute inpatient rehab volumes are rising with an aging population, and reimbursement trends have turned more favorable. The business is operationally levered, so labor cost inflation is the primary margin risk. |
| APA | APA Corporation | Energy | Oil & Gas E&P | 1.607e+10 | -3.23% | 51.34% | — | 9.68 | 10.75 | 3.03% | 20.40% | 18.84% | 70 | 64 | Permian and Egypt oil leverage with a Suriname development option; earnings are a direct function of crude prices and the company carries meaningful debt. Valuation is cheap because the market discounts the commodity cycle. |
| FRHC | Freedom Holding Corp. | Financials | Financial Conglomerates | 1.082e+10 | -3.81% | 100.99% | 9.34% | 70.39 | 37.7 | 4.25% | 12.47% | 11.36% | 32.9 | — | A retail brokerage with outsized exposure to emerging-market clients; growth has been driven by account additions and a favorable trading backdrop. Governance and disclosure concerns have historically kept the valuation discount wide. |
| TWLO | Twilio Inc. | Information Technology | Software - Infrastructure | 4.446e+10 | -3.92% | 130.93% | 13.66% | 39.98 | 42.62 | 25.24% | 146.04% | 46.11% | 97.1 | 63 | The communications-platform business is being repositioned around software gross margins and AI-enabled customer data, and profitability is inflecting from a low base. Growth deceleration in the legacy messaging business remains the debate. |
| SN | SharkNinja, Inc. | Consumer Discretionary | Furnishings, Fixtures & Appliances | 2.618e+10 | -4.09% | 59.87% | 15.75% | 37.75 | 24.14 | 13.78% | 77.61% | 31.00% | 99.3 | 65 | A consumer-products compounder built on innovation and shelf-space wins across kitchen and beauty categories, with international expansion as the next leg. Tariff and freight cost exposure is the main near-term earnings variable. |
| NVDA | NVIDIA Corporation | Information Technology | Semiconductors | 5.536e+12 | -4.16% | 64.75% | 65.47% | 35.11 | 17.86 | 5.00% | 21.83% | 10.63% | 99.9 | 43 | The AI accelerator franchise still sets the pace for the entire compute cycle, and demand remains supply-constrained. The risk is no longer demand but hyperscaler digestion and the eventual shift of wallet share toward custom silicon. |
| CNQ | Canadian Natural Resources Limi | Energy | Oil & Gas E&P | 8.562e+10 | -4.17% | 77.20% | 8.71% | 12.26 | 12.99 | -1.39% | 9.24% | 7.84% | 52.7 | 63 | Long-life oil sands with low decline rates generate free cash flow across the cycle, and the shareholder-return framework is a differentiator. Heavy oil differentials and Canadian energy policy are the recurring risks. |
| KO | Coca-Cola Company (The) | Consumer Staples | Beverages - Non-Alcoholic | 3.788e+11 | -4.28% | 23.36% | 1.87% | 26.44 | 24.97 | 0.85% | 15.07% | 7.80% | 61 | 73 | A defensive pricing-power franchise where volume growth is modest but the brand and distribution keep cash flow steady; the setup is about margin recovery and currency. Growth here is structurally slow, which caps re-rating potential. |
| ROKU | Roku, Inc. | Communication Services | Entertainment | 2.27e+10 | -4.33% | 168.29% | 15.18% | 64.49 | 38.96 | -0.82% | 49.17% | 15.36% | 99 | 63 | The shift to streaming-advertising and platform distribution is driving the profit inflection, and engagement metrics are stabilizing. Competition for ad dollars and content costs are the persistent swing factors. |
| CAH | Cardinal Health, Inc. | Health Care | Medical Distribution | 5.501e+10 | -4.44% | 83.94% | -1.87% | 32.81 | 16.94 | 0.89% | 10.73% | 8.33% | 48.7 | 59 | Pharmaceutical distribution benefits from specialty-drug volume and pricing, with the low-margin core business masking improving mix. Payer/political pressure on drug pricing is the structural risk. |
| QRVO | Qorvo, Inc. | Information Technology | Semiconductors | 1.007e+10 | -4.53% | 509.53% | -1.09% | 26.49 | 14.34 | 13.74% | 43.74% | 22.41% | 92.9 | 68 | A smartphone-RF supplier whose earnings are recovering as inventory normalizes, with content gains in premium handsets as the swing factor. Customer concentration makes results lumpy and the growth optics base-driven. |
| BBD | Banco Bradesco Sa | Financials | Banks - Regional | 4.553e+10 | -4.66% | 36.38% | — | 10.24 | 7.67 | 20.24% | 9.52% | 22.26% | 50.9 | 64 | A Brazilian bank levered to falling local rates and improving credit quality, which is why earnings are inflecting. The setup is a classic EM macro story — currency and fiscal headlines dominate fundamentals. |
| SCCO | Southern Copper Corporation | Materials | Copper | 1.766e+11 | -4.77% | 28.32% | 17.38% | 31.37 | 29.31 | 7.76% | 14.25% | 13.63% | 62 | 80 | Copper supply is structurally tight while electrification and grid investment lift demand, and this low-cost producer is a direct play on that deficit. The valuation already embeds high copper prices, so a global growth scare is the risk. |
| SBS | Companhia de saneamento Basico | Utilities | Utilities - Regulated Water | 2.37e+10 | -4.83% | 171.87% | 41.35% | 14.98 | 13.95 | 26.69% | -1.20% | 18.35% | 78.1 | 57 | Brazilian water and sanitation spending is a multi-year capex cycle supported by favorable regulatory terms and population growth. Earnings are solid but the currency and rate backdrop in Brazil drive the multiple. |
Screen
What this screen is picking up
The intersection of price leadership and earnings acceleration — 42 names over $10B that sit within 5% of a 52-week high while still growing EPS more than 20% year over year — is unusually tilted toward Information Technology, and within tech, toward software infrastructure and AI plumbing rather than cyclical semis (though NVIDIA, Arista, Amphenol and ASE are all present). That matches the current tape: software, cyber and data-center infrastructure are being bought as AI-adoption toll collectors, while the rate-sensitive value complex keeps leaking.
Structural vs. cyclical earnings
A large share of the EPS growth on this list is cyclical or base-driven, not structural. Refiners (HF Sinclair, Phillips 66), packagers/energy producers (APA, Canadian Natural) and Brazil-levered financials (Banco Bradesco, Companhia Paranaense) are riding commodity spreads, crack margins and local currency recovery — their earnings power will mean-revert with the cycle. Several high-growth-percentage names are also recovering from depressed or near-zero prior-year bases, so the headline growth rate overstates the run-rate.
By contrast, the software/security/data-center cluster (Palantir, Okta, Nutanix, Arista, Amphenol, NVIDIA, Dell) is growing off a genuine demand cycle, though each carries a valuation that already discounts several years of that growth.
What to watch
- Earnings season is the catalyst. Most names here are 60+ days past their last report, meaning the next print — not a recent one — is what re-rates them. Guidance risk is elevated.
- Extensions are large. Many of these trade far above their 150-day averages, which raises the cost of being wrong and makes pullback entries more attractive than chasing.
- Concentration in AI capex. A meaningful slice of the list shares one macro dependency: hyperscaler and data-center spending. Diversifying within the screen means leaning on the health-care, insurance and consumer-staples names.
Run a version of this yourself
Describe the idea in plain English and Relaxfolio returns a researchable shortlist with the charts, fundamentals, and risks attached.
Educational research tool — not investment advice. A screen is a starting point, not a recommendation.